V. Paparizos

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

J. Robins, M. Hernán, J. Sterne, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cutaneous markers of HIV infection.

A. Katsambas, D. Rigopoulos, V. Paparizos, 2004, Clinics in dermatology.

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes

J. Robins, M. Hernán, J. Sterne, 2016, Medicine.

AIDS in pregnancy, part II: Treatment in the era of highly active antiretroviral therapy and management of obstetric, anesthetic, and pediatric issues.

A. Katsambas, S. Gregoriou, D. Rigopoulos, 2007, Skinmed.

AIDS in pregnancy, part I: epidemiology, testing, effect on disease progression, opportunistic infections, and risk of vertical transmission.

A. Katsambas, S. Gregoriou, D. Rigopoulos, 2007, Skinmed.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Virological and Immunological Response to HAART Therapy in a Community-Based Cohort of HIV-1-Positive Individuals

A. Hatzakis, G. Touloumi, A. Antoniadou, 2001, HIV clinical trials.

Mutations associated with genotypic resistance to antiretroviral therapy in treatment naïve HIV-1 infected patients in Greece.

G. Magiorkinis, A. Hatzakis, D. Paraskevis, 2002, Virus research.

Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.

E. Magiorkinis, A. Hatzakis, D. Paraskevis, 2005, Virus research.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Jan Albert, Kirsi Liitsola, Mario Poljak, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.